Prevalence and clinical management of complicated urinary tract infections in Italy: A prospective multicenter epidemiological study in urological outpatients

Journal of Chemotherapy

Volumn 17, Issue 6, 2005, Pages 601-606

  Ferri, C ^a   Marchetti, Federico ^b   Nickel, J C ^c   Naber, K G ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b GSK   (Italy)

^c QUEEN S UNIVERSITY   (Canada)

^d Urologische Klinik   (Germany)

Author keywords

Complicated urinary tract infection; Urinary tract infection; UTI

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYSTOCELE; CYSTOURETHROGRAPHY; DIABETES MELLITUS; ECHOGRAPHY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; HYSTERECTOMY; INFECTION COMPLICATION; ITALY; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHYSICIAN ATTITUDE; PREVALENCE; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROTEUS MIRABILIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; REINFECTION; STAPHYLOCOCCUS; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; UROFLOWMETRY; UROLITHIASIS; UROLOGIC SURGERY;

EID: 30744447228     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.6.601     Document Type: Article

References (16)

1. Melekos MD, Naber K. Complicated urinary tract infections. Int J Antimicrob Agents 2000; 15: 247-256.
2. Nicolle LE. Epidemiology of urinary tract infections. Infect Med 2001; 18: 153-162.
3. Ruben FL, Dearwater ST, Norden CW. Clinical infections in the non-istituzionalized geriatric group: methods utilized and prevalence of infections. Am J Epidemiol 1995; 141: 145-157.
4. Privitera G, Visona' G, Porretta A, Panceri L, Marchetti F. Epidemiologia e modalita' di gestions delle infezioni batteriche nei servizi di pronto soccorso degli ospedali italiani. Atti del 39mo Congresso Nazionale della Società Italiana di Igiene, Ferrara, 24-25 settembre 2000.
5. Bosisio V, Stella R, Castagna S, Marchetti F. A prospective, descriptive study on the practise of management of urinary tract infections by general pratictioners in Italy: epidemiology (Part I). Archivio Italiano di Urologia e Andrologia 2003; 75 (2): 9-12.
6. Rizzo M, Marchetti F, Travaglini F, Trinchieri A, Nickel JC. Prevalence, diagnosis and treatment of prostatitis In Italy: a prospective observational urology outpatient practice study. British J Urol Int 2003; 92: 955-959.
7. Frea B. La gestione ambulatoriale delle infezioni urinarie in Italia: aspetti epidemiologici, diagnostici e terapeutici. Studio multicentrico nazionale. Atti del 74mo Congresso Nazionale Società Italiana di Urologia, Cagliari, 12-18 giugno 2001.
8. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity and economic costs. Am J Med 2002; 113 (1A): 5S-13S.
9. Warren W, Abrutyn E, Hebel R, Johnson J, Schaeffer A, Stamm W. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745-58.
10. Naber K, Bergman B, Bishop MC, et al. EAU Guidelines for the management of urinary and male genital tract infections. Eur Urolol 2001; 40: 576-588.
11. Rubin RH, Shapiro ED, Andriole VT, Davies RJ, Stamm WE. General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infections. Clin Infect Dis 1992; 15 (Suppl 1): 216-27.
12. Obana Y, Shibata K, Nishimo T, Adherence of Serratia marcescens in the patogénesis of urinary tract infections in diabetic mice. J Med Microbiol 1991; 35: 93-97.
13. Bernard AM, Ouled M, Lauwerys RR, Lambert A, Vandeleene R. Pronounced decrease of Tamm-Horsfall proteinuria in diabetics. Clin Chem 1987; 33: 1624.
14. Schito GC, Chezzi C, Nicoletti G, et al. Susceptibility of frequent urinary pathogens to fosfomycin trometamol and eight other antibiotics: results of an Italian multicentre survey. Infection 1992; 20 (Suppl 4): S291-S295.
15. Marchese A, Gualco L, Debbia E, Schito GC, Schito AM. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int J Antimicrob Agents 2003; 22: S53-S59.
16. Gesu GP, Marchetti F, Piccoli L, Cavallero A. Levofloxacin and ciprofloxacin in vitro activity on 4003 bacterial clinical isolates collected in 24 Italian laboratories. Antimicrob Agents Chemother 2003; 47 (2): 816-819.